ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GERN Geron Corp

2.00
0.07 (3.63%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Geron Corp GERN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.07 3.63% 2.00 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.92 1.87 1.995 1.99 1.93
more quote information »

Recent News

Date Time Source Heading
11/28/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/28/202315:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/28/202315:05EDGAR2Form 8-K - Current report
11/28/202307:00BWGeron Corporation Announces Appointment of Gaurav Aggarwal,..
11/16/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
11/07/202315:30BWGeron to Participate at Upcoming Investor Conferences in..
11/02/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/02/202308:00BWGeron IMerge Phase 3 Presentations at Upcoming ASH Annual..
11/02/202307:50EDGAR2Form 8-K - Current report
11/02/202307:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:00BWGeron Corporation Reports Business Highlights and Third..
10/26/202315:30BWGeron to Announce Third Quarter 2023 Financial Results on..
10/19/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
10/02/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/29/202308:02EDGAR2Form 8-K - Current report
9/29/202307:00BWGeron Announces EMA Validation of Marketing Authorization..
9/27/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/27/202318:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/21/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/21/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/21/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/21/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/12/202308:23IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
9/11/202315:30BWGeron Announces Appointment of Michelle Robertson as..
9/07/202307:00BWGeron Announces Data Presentations from IMerge Phase 3..
9/05/202315:30BWGeron to Participate in the Baird 2023 Global Healthcare..
8/24/202319:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202315:59EDGAR2Form 8-K - Current report
8/22/202307:00BWGeron Announces PDUFA Date for Imetelstat NDA in Lower Risk..
8/21/202307:00BWGeron Announces FDA Acceptance of New Drug Application for..
8/17/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
8/03/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202317:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/03/202316:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
8/03/202315:24EDGAR2Form 8-K - Current report
8/03/202315:05BWGeron Corporation Reports Business Highlights and Second..
8/03/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/27/202315:30BWGeron to Announce Second Quarter 2023 Financial Results on..
7/20/202315:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
6/30/202320:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/30/202320:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/30/202320:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/29/202307:30BWGeron Announces U.S. Expanded Access Protocol for Imetelstat..
6/22/202315:30BWGeron Reports Inducement Grant Under Nasdaq Listing Rule..
6/20/202308:00BWGeron Announces Submission of New Drug Application to FDA..
6/13/202308:00BWGeron Announces First Patient Dosed in Investigator-Led..
6/12/202307:00BWGeron Announces New Data and Analyses from IMerge Phase 3..
6/07/202315:30BWGeron to Participate in Goldman Sachs 44th Annual Global..
6/06/202315:30BWGeron to Host Virtual Investor Event on June 14, 2023

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com